StockData
AtriCure, Inc. logo

AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30893% above fair value
$55.45+0.43 (+0.78%)

Close on Nov 18, 2026Market cap $2.82BP/E 264.0Yield –

AtriCure operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

AtriCure's operating income for the twelve months ending Jun 30, 2026 was $12.89M. For fiscal 2025 it was -$9.45M. The highest annual figure on record is $55.21M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.45M–
FY2024Dec 31, 2024-$40.01M–
FY2023Dec 31, 2023-$26.68M–
FY2022Dec 31, 2022-$42.67M-177.3%
FY2021Dec 31, 2021$55.21M–
FY2020Dec 31, 2020-$44.23M–
FY2019Dec 31, 2019-$33.12M–
FY2018Dec 31, 2018-$17.13M–
FY2017Dec 31, 2017-$24.98M–
FY2016Dec 31, 2016-$31.14M–
FY2015Dec 31, 2015-$26.72M–
FY2014Dec 31, 2014-$16.36M–
FY2013Dec 31, 2013-$10.89M–
FY2012Dec 31, 2012-$7.20M–
FY2011Dec 31, 2011-$4.73M–
FY2010Dec 31, 2010-$3.19M–
FY2009Dec 31, 2009-$15.51M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.67M–
Q1 FY2026Mar 31, 2026$526.00K–
Q4 FY2025Dec 31, 2025$2.49M–
Q3 FY2025Sep 30, 2025$208.00K–
Q2 FY2025Jun 30, 2025-$6.19M–
Q1 FY2025Mar 31, 2025-$5.95M–
Q4 FY2024Dec 31, 2024-$14.52M–
Q3 FY2024Sep 30, 2024-$7.41M–
Q2 FY2024Jun 30, 2024-$7.17M–
Q1 FY2024Mar 31, 2024-$10.92M–
Q4 FY2023Dec 31, 2023-$8.67M–
Q3 FY2023Sep 30, 2023-$8.09M–
Q2 FY2023Jun 30, 2023-$4.14M–
Q1 FY2023Mar 31, 2023-$5.78M–
Q4 FY2022Dec 31, 2022-$4.14M–
Q3 FY2022Sep 30, 2022-$10.72M-110.9%
Q2 FY2022Jun 30, 2022-$13.66M–
Q1 FY2022Mar 31, 2022-$14.15M–
Q4 FY2021Dec 31, 2021-$12.50M–
Q3 FY2021Sep 30, 2021$98.67M–
Q2 FY2021Jun 30, 2021-$15.08M–
Q1 FY2021Mar 31, 2021-$15.89M–
Q4 FY2020Dec 31, 2020-$17.50M–
Q3 FY2020Sep 30, 2020-$3.99M–
Q2 FY2020Jun 30, 2020-$7.29M–
Q1 FY2020Mar 31, 2020-$15.45M–
Q4 FY2019Dec 31, 2019-$15.33M–
Q3 FY2019Sep 30, 2019-$8.64M–
Q2 FY2019Jun 30, 2019-$3.84M-500.7%
Q1 FY2019Mar 31, 2019-$5.32M–
Q4 FY2018Dec 31, 2018-$2.61M–
Q3 FY2018Sep 30, 2018-$6.05M–
Q2 FY2018Jun 30, 2018$958.00K–
Q1 FY2018Mar 31, 2018-$9.43M–
Q4 FY2017Dec 31, 2017-$2.14M–
Q3 FY2017Sep 30, 2017-$6.85M–
Q2 FY2017Jun 30, 2017-$6.36M–
Q1 FY2017Mar 31, 2017-$9.64M–
Q4 FY2016Dec 31, 2016-$7.70M–
Q3 FY2016Sep 30, 2016-$6.29M–

More AtriCure figures

See a number that looks wrong?